• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过酶联免疫吸附测定(ELISA)检测新型隐球菌感染患者体内的磷脂酶B抗体。

Detection of antibodies to phospholipase B in patients infected with Cryptococcus neoformans by enzyme-linked immunosorbent assay (ELISA).

作者信息

Santangelo R T, Chen S C, Sorrell T C, Wright L C

机构信息

Centre for Infectious Diseases and Microbiology, University of Sydney, Westmead Hospital, Westmead, New South Wales, Australia.

出版信息

Med Mycol. 2005 Jun;43(4):335-41. doi: 10.1080/13693780412331282331.

DOI:10.1080/13693780412331282331
PMID:16110779
Abstract

Secreted phospholipases are virulence factors of several fungi, including Cryptococcus neoformans. We describe for the first time the detection by ELISA of antibodies to cryptococcal phospholipase B in the serum of patients infected with C. neoformans or C. gattii. Sixty-nine sera from 25 patients with cryptococcosis, 23 patients with Candida infections and 26 with bacterial or viral infections were tested. The sensitivity of the ELISA in patients with cryptococcosis was 100% in immunocompetent hosts and 64.3% in immunosuppressed patients with cryptococcal meningitis. Absorbance readings were significantly higher in immunocompetent patients (P<0.001). Titres remained positive for up to 2 years. Positive results were noted in 10 episodes of invasive candidiasis, three patients colonised with Candida, and three cases of bacterial infection. Mean absorbance readings were significantly lower in patients with bacterial infection (P <0.001). We conclude that phospholipase B is produced in vivo during cryptococcal infection and that serum phospholipase B antibodies are a sensitive marker of present or past infection. Cross-reactivity of the ELISA with sera from patients with candidiasis indicates that common epitopes are present on cryptococcal and candidal phospholipase B, hence fungal phospholipase B may constitute a new therapeutic target.

摘要

分泌型磷脂酶是包括新型隐球菌在内的几种真菌的毒力因子。我们首次描述了通过酶联免疫吸附测定法(ELISA)检测新型隐球菌或格特隐球菌感染患者血清中针对隐球菌磷脂酶B的抗体。对来自25例隐球菌病患者、23例念珠菌感染患者以及26例细菌或病毒感染患者的69份血清进行了检测。该ELISA对免疫功能正常的隐球菌病患者的敏感性为100%,对免疫抑制的隐球菌性脑膜炎患者的敏感性为64.3%。免疫功能正常患者的吸光度读数显著更高(P<0.001)。抗体滴度在长达2年内保持阳性。在10例侵袭性念珠菌病、3例念珠菌定植患者以及3例细菌感染患者中检测到阳性结果。细菌感染患者的平均吸光度读数显著更低(P <0.001)。我们得出结论,在隐球菌感染期间磷脂酶B在体内产生,血清磷脂酶B抗体是当前或既往感染的敏感标志物。ELISA与念珠菌病患者血清的交叉反应表明,隐球菌和念珠菌的磷脂酶B存在共同表位,因此真菌磷脂酶B可能构成一个新的治疗靶点。

相似文献

1
Detection of antibodies to phospholipase B in patients infected with Cryptococcus neoformans by enzyme-linked immunosorbent assay (ELISA).通过酶联免疫吸附测定(ELISA)检测新型隐球菌感染患者体内的磷脂酶B抗体。
Med Mycol. 2005 Jun;43(4):335-41. doi: 10.1080/13693780412331282331.
2
Cryptococcal phospholipase B antigen is not detected in serum of patients infected with Cryptococcus neoformans using a sandwich enzyme-linked immunosorbent assay.
FEMS Yeast Res. 2007 May;7(3):465-70. doi: 10.1111/j.1567-1364.2006.00187.x. Epub 2007 Jan 15.
3
Serologic evidence for Cryptococcus neoformans infection in early childhood.儿童期早期新型隐球菌感染的血清学证据。
Pediatrics. 2001 May;107(5):E66. doi: 10.1542/peds.107.5.e66.
4
Serum antibody response to Cryptococcus neoformans in cats, dogs and koalas with and without active infection.有或无活动性感染的猫、狗和树袋熊对新型隐球菌的血清抗体反应。
Med Mycol. 1999 Feb;37(1):43-51.
5
T cell response to soluble cryptococcal antigens after recovery from cryptococcal infection.从隐球菌感染中恢复后T细胞对可溶性隐球菌抗原的反应。
J Infect Dis. 1989 Jan;159(1):116-9. doi: 10.1093/infdis/159.1.116.
6
Serum antibody response to active infection with Cryptococcus neoformans and its varieties in immunocompetent subjects.免疫功能正常个体对新型隐球菌及其变种主动感染的血清抗体反应。
J Med Vet Mycol. 1996 Jun-Jul;34(3):187-93.
7
Pitfalls in Serological Diagnosis of Cryptococcus gattii Infections.隐球菌属感染血清学诊断的陷阱。
Med Mycol. 2015 Nov;53(8):874-9. doi: 10.1093/mmy/myv061. Epub 2015 Sep 2.
8
Antibody responses to Cryptococcus neoformans in Indian patients with cryptococcosis.印度隐球菌病患者对新型隐球菌的抗体反应。
Med Mycol. 2008 Aug;46(5):457-63. doi: 10.1080/13693780801961345. Epub 2008 Mar 10.
9
Antibodies reactive with the cryptococcal capsular polysaccharide glucuronoxylomannan are present in sera from children with and without human immunodeficiency virus infection.与隐球菌荚膜多糖葡糖醛酸木糖甘露聚糖反应的抗体存在于感染和未感染人类免疫缺陷病毒的儿童血清中。
J Infect Dis. 1999 Sep;180(3):915-9. doi: 10.1086/314953.
10
Antibody response to Cryptococcus neoformans proteins in rodents and humans.啮齿动物和人类对新型隐球菌蛋白的抗体反应。
Infect Immun. 1999 May;67(5):2218-24. doi: 10.1128/IAI.67.5.2218-2224.1999.

引用本文的文献

1
Virulence profile of pathogenic yeasts from snakes: Alternative ways for antifungal strategies.蛇源致病性酵母的毒力特征:抗真菌策略的替代方法。
PLoS One. 2025 Mar 12;20(3):e0318703. doi: 10.1371/journal.pone.0318703. eCollection 2025.
2
Role of phospholipases in fungal fitness, pathogenicity, and drug development - lessons from cryptococcus neoformans.磷脂酶在真菌适应性、致病性及药物研发中的作用——来自新型隐球菌的经验教训
Front Microbiol. 2010 Nov 11;1:125. doi: 10.3389/fmicb.2010.00125. eCollection 2010.
3
SEC14 is a specific requirement for secretion of phospholipase B1 and pathogenicity of Cryptococcus neoformans.
SEC14 是磷脂酶 B1 分泌和新型隐球菌致病性的特定要求。
Mol Microbiol. 2011 May;80(4):1088-101. doi: 10.1111/j.1365-2958.2011.07632.x. Epub 2011 Mar 31.
4
Phospholipase A2 and phospholipase B activities in fungi.真菌中的磷脂酶A2和磷脂酶B活性
Biochim Biophys Acta. 2006 Nov;1761(11):1391-9. doi: 10.1016/j.bbalip.2006.09.011. Epub 2006 Oct 3.